Breast cancer's cruelest mystery has long been why two patients with seemingly identical tumors can face such different fates. A new study published in Nature proposes that the answer may be written in the mitochondria — the cell's ancient energy-generating machinery — and the genes that govern how tumors burn fuel to survive and spread. By building a statistical framework from mitochondrial metabolism-associated genes, researchers have not only found a way to stratify patients by risk, but have identified a single gene, MTDH, whose silencing measurably strips cancer cells of their capacity to